News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Special WCLC24 Lung Cancer Considered episode
Photo taken from IASLC/X
Sep 10, 2024, 11:08

Special WCLC24 Lung Cancer Considered episode

IASLC (International Association for the Study of Lung Cancer) shared a post on X:

“ In this special WCLC24 Lung Cancer Considered episode, host Stephen V Liu discusses daily highlights from the conference with guests IASLC President Elect Caicun Zhou, Tina Cascone, Marina Garassino and Matthew Smeltzer.

Listen now.”

Source: IASLC/X

Caicun Zhou cancer IASLC International Association for the Study of Lung Cancer Lung Cancer Considered Marina Garassino Matthew Smeltzer OncoDaily Oncology Stephen V Liu Tina Cascone WCLC24
Special Coverage
Societies
Sep 10, 2024, 11:08
Special WCLC24 Lung Cancer Considered episode
Blog
Sep 10, 2024, 10:59
Eiffel Tower requested 300,000 USD for Lighting the tower for Childhood Cancer Month?
Blog
Sep 10, 2024, 10:53
Zainab Shinkafi-Bagudu: I had the privilege of attending the Oxford Academy 2024 training on 'Managing Innovation: Financing Health Systems and Digital Health' for World Health Leaders
Insight
Sep 10, 2024, 10:47
Gerry Hanna: Irish Lung Cancer community together at WCLC24
Blog
Sep 10, 2024, 10:45
Sara Tolaney: Mark your calendars for PER’s School of Breast Oncology
Blog
Sep 10, 2024, 10:43
Shibu Varghese: Tadd Pullin joins MD Anderson Cancer HR team for yearly strategically planning
Blog
Sep 10, 2024, 10:39
Ayomide Omotola: Sparking hope in East Africa as we tackle childhood cancer in Kenya and Uganda
Blog
Sep 10, 2024, 10:38
Vivek Subbiah: Precision Dosing IS Precision Oncology
Insight
Sep 10, 2024, 10:30
AIM-HI announces the 2024 Women's Venture Competition's first prize winner
Blog
Sep 10, 2024, 10:28
Matthew Herper: Facing cancer is hard -- even if you're someone who would change the way we treat cancer
Insight
Sep 10, 2024, 07:24
Vivek Subbiah: Precision medicine and tumor-agnostic therapies are leading the conversation at the ESMO24
Blog
Sep 10, 2024, 06:58
Discussion on the only adjuvant study that was positive for RCC by Chandler Park